Diabetes: targeting an old adversary.
For the first time in almost 20 years, new recommendations on diagnosis, classification, and testing strategies for diabetes have been issued. For clinical labs, combatting this old enemy under the new guidelines will include expanded patient screening and closer monitoring. Learn about the high-risk groups in the U.S. population, the long-term effects of diabetes, and how changes in testing approaches can improve disease management and patient outcomes.